🔎 Trials Near Me

首页 › 骨髓增生异常综合征 › 肯塔基州

肯塔基州 的 骨髓增生异常综合征 临床试验

肯塔基州 有 5 项针对 骨髓增生异常综合征 的研究正在招募参与者。

肯塔基州 的城市

官方研究文本（英文）

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

  • University of Kentucky/Markey Cancer Center, Lexington
  • The James Graham Brown Cancer Center at University of Louisville, Louisville
  • UofL Health Medical Center Northeast, Louisville
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年10月5日 · NCT05564390

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

  • The James Graham Brown Cancer Center at University of Louisville, Louisville
  • UofL Health Medical Center Northeast, Louisville
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年10月5日 · NCT06577441

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

  • Norton Cancer Institute, Louisville
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月18日 · NCT07422480

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  • University of Kentucky/Markey Cancer Center, Lexington
  • Norton Children's Hospital, Louisville
招募中1/2 期
22 岁及以下 · 所有性别 · 更新于 2026年8月25日 · NCT04726241

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

  • Norton Cancer Institute, Louisville
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年8月21日 · NCT06499285

数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。